Effect of fish-oil supplementation on the glycemic and lipidemic profiles of pregnant women: a systematic review and meta-analysis
- 5 February 2024
- journal article
- review article
- Published by Oxford University Press (OUP) in Nutrition Reviews
- Vol. 82 (12) , 1756-1770
Abstract
Pregnant women have physiological metabolic changes in glycemic and lipid profiles that are essential for fetal development. The aim of this systematic review was to analyze the effects of fish-oil-capsule supplementation on the glycemic and lipid profiles of pregnant women. A systematic search was conducted of the MEDLINE (by PubMed), Embase, Cochrane Library (CENTRAL) databases and gray literature, including preprints for all relevant studies published in English, with no date restrictions. The estimated pooled results were analyzed using a random-effects model and represented by mean differences (MDs) and corresponding 95% confidence intervals (CIs). The analyses were performed with R software, version 4.2.1, using the “Meta” packages, versions 6.0-0. Fifteen eligible studies were included after screening. In a pooled analysis, overall fish-oil supplementation had no effect on parameters compared with placebo. In the subgroup analysis, fish-oil supplementation may be beneficial in insulin (MD: –2.11 IU/mL; 95% CI: –3.86, –0.36) and homeostasis model assessment of insulin resistance (HOMA-IR) (MD: –0.71; 95% CI: –1.14, –0.29) indices, with heterogeneity (I2 =0%) among pregnant women with diabetes mellitus. In the subgroup with doses of eicosapentaenoic acid (EPA) below 200 mg, there was a reduction in HOMA-IR in the intervention group (MD: –0.60; 95% CI: –1.14, –0.06). Pregnant women taking fish-oil capsules showed significant beneficial changes in the subgroups of type 2 diabetes and EPA dosages below 200 mg for insulin and HOMA-IR.Keywords
This publication has 36 references indexed in Scilit:
- Fish-oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsiaThe American Journal of Clinical Nutrition, 2012
- Omega 3 fatty acids, gestation and pregnancy outcomesBritish Journal of Nutrition, 2012
- Effects of Eicosapentaenoic Acid Versus Docosahexaenoic Acid on Serum Lipids: A Systematic Review and Meta-AnalysisCurrent Atherosclerosis Reports, 2011
- Position of the American Dietetic Association: Nutrient SupplementationJournal of the American Dietetic Association, 2009
- Diabetes mellitus gestacionalRevista da Associação Médica Brasileira, 2008
- n− 3 Fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipidsClinical Science, 2006
- Insulin resistance and pancreatic cell failureJournal of Clinical Investigation, 2006
- Supplementation of n-3 fatty acids during pregnancy and lactation reduces maternal plasma lipid levels and provides DHA to the infantsThe Journal of Maternal-Fetal & Neonatal Medicine, 2006
- Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) studyThe Lancet, 1999
- Multiple Beneficial Effects of Estrogen on Lipoprotein MetabolismThe Journal of Clinical Endocrinology & Metabolism, 1997